长风药业股份有限公司（股票代码：02652）于2026年5月4日发布公告，披露当日在香港联交所场内回购股份的最新情况。
本次合共回购5500股普通H股，占回购前已发行股本约0.0018%。每股回购价格介乎21.98港元至22.78港元，总耗资约12.35万港元。回购完成后，公司已发行股本变为301,553,086股，库存股数增至670,500股。
公司于2025年12月16日获得股东大会通过的回购授权，总共可回购30,222,358股。截至本公告日，公司依据该授权已在联交所或其他证券交易所合计回购670,500股。
公司确认上述股份回购已获董事会正式批准，并遵守了相关上市规则及适用法律法规。本公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.